SELENOP and COVID-19: Lower Se and Sepp1 levels were reportedly detected in COVID-19 patients across various nations, such as Belgium’s intensive care unit short-stayers (7–11 days), Germany’s deceased cases compared to discharges, India’s male patients, Nigeria’s patients, Russia’s moderate to severe cases, South Korea’s severe cases, and Turkey’s pregnant women with COVID-19 [20].